Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation leading to immune exhaustion and eventual resistance to immunotherapy, ...

Researchers have tested a new cancer drug in pet cats with head and neck squamous cell carcinoma – a disease notoriously hard to treat. The trial showed the therapy controlled cancer in 35 percent of ...

Researchers have discovered that statins, drugs typically used for high cholesterol, could potentially slow the growth of colorectal cancer cells.

The field of oncology has witnessed remarkable strides in early detection and treatment, yet cancer remains a formidable threat with high mortality rates ...

"We are uniquely positioned to support Synthetic Design Lab’s development of novel antibody-drug conjugates for various ...

Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish ...

U.S. Gene Editing Market to Expand from USD 1.95 Billion in 2024 to USD 4.82 Billion by 2032, Driven by Growing Therapeutic Applications, Federal Research Funding, and Biotech Investments.Austin, Sept ...

Drug repurposing, an alternative to the conventional way of developing medicines from scratch, accelerates the pace of discovery since existing medicines and compounds being used for it have already ...

Statins, which help treat high cholesterol, have been found to slow down the growth of colorectal tumours, according to a new study, making researchers consider the possibility of repurposing the drug ...

Servier, an independent international pharmaceutical group governed by a foundation, and IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced an ...

These metabolic axes have a profound impact on virtually all aspects of our functioning, influencing not only the metabolic health but also the immune system and even cancer.

Triple-negative breast cancer (TNBC), the deadliest breast cancer subtype, disproportionately affects African American women—but until now, they have been underrepresented in genomic studies aimed at ...